Press Release




FDA Approves Cosela

On February 12, the U.S. Food and Drug Administration (FDA) approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of…


Janssen COVID-19 Vaccine Candidate

On January 29, Johnson & Johnson company announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose…